Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-13-018528
Filing Date
2013-05-29
Accepted
2013-05-29 09:00:04
Documents
2
Period of Report
2013-05-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 7143
2 POWER OF ATTORNEY doc1.htm EX-24 4801
  Complete submission text file 0001127602-13-018528.txt   13143
Mailing Address 65 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE LEXINGTON MA 02421 781-860-8660
CUBIST PHARMACEUTICALS INC (Issuer) CIK: 0000912183 (see all company filings)

EIN.: 223192085 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
CORRIGAN MARK (Reporting) CIK: 0001250661 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21379 | Film No.: 13876786